4 research outputs found
Inhaled dry salt micro particles in the treatment of bronchopulmonary dysplasia: a five case series report
Background. Despite current medical advances,
to this day there is no single medical
intervention to effectively prevent or
treat bronchopulmonary dysplasia (BPD)
in both preterm and term infants. Along
with protective ventilation strategies, various
drugs are being used or are being researched
at this very moment, with the sole
purpose of improving the general outcome
for these patients. Inhaled dry salt micro
particles therapy is now one of them.
Materials and methods. This report presents
five patients, diagnosed with severe
BPD. All of them received, complementary
to classical BPD management and
respiratory support, continuous inhaled
dry salt micro particles, via SaltMed cartridges,
for a period of 12 to 30 days. After
only 24 hours of administration, we were
able to observe a significant improvement
in respiratory function and dynamics. It
was possible to use a lower fraction of inspired
oxygen (FiO2), mean airway pressure
(MAP) and peak inspiratory pressure
(PIP) in all mechanically ventilated patients.
Higher tidal volumes were recorded
and we observed improvement in oxygenation
indexes.
Conclusion. Continuously inhaled dry salt
micro particles, administered complementary
to classic BPD management, could
improve respiratory and overall morbidity
and mortality in infants with any form
of BPD. Further study of these possible
effects is needed, as there is no data published
on this matter so far
Regulation of TRPM8 channel activity by Src-mediated tyrosine phosphorylation
The transient receptor potential melastatin type 8 (TRPM8) receptor channel is expressed in primary afferent neurons where it is the main transducer of innocuous cold temperatures and also in a variety of tumors, where it is involved in progression and metastasis. Modulation of this channel by intracellular signaling pathways has therefore important clinical implications. We investigated the modulation of recombinant and natively expressed TRPM8 by the Src kinase, which is known to be involved in cancer pathophysiology and inflammation. Human TRPM8 expressed in HEK293T cells is constitutively tyrosine phosphorylated by Src which is expressed either heterologously or endogenously. Src action on TRPM8 potentiates its activity, as treatment with PP2, a selective Src kinase inhibitor, reduces both TRPM8 tyrosine phosphorylation and cold‐induced channel activation. RNA interference directed against the Src kinase diminished the extent of PP2‐induced functional downregulation of TRPM8, confirming that PP2 acts mainly through Src inhibition. Finally, the effect of PP2 on TRPM8 cold activation was reproduced in cultured rat dorsal root ganglion neurons, and this action was antagonized by the protein tyrosine phosphatase inhibitor pervanadate, confirming that TRPM8 activity is sensitive to the cellular balance between tyrosine kinases and phosphatases. This positive modulation of TRPM8 by Src kinase may be relevant for inflammatory pain and cancer signaling